Comparison of the Suppression of Cell and Virus Growth in Transformed Human Cells by Leukocyte and Fibroblast Interferon

References

1. Anfinsen C. B., Bose S., Corley L., Gurari-Rotman D. 1974; Partial purification of human interferon by affinity chromatography. Proceedings of the National Academy of Sciences of the United States of America 71:3139–3142
   [Google Scholar]
2. Berg K., Ogburn C. A., Paucker K., Mogensen K. E., Cantell K. 1975; Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. Journal of Immunology 114:640–644
   [Google Scholar]
3. Borecky L., Fuchsberger N., Hajnicka-Gondova V., Ciampor F., Altaner C. F. 1977; The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma 24:125–137
   [Google Scholar]
4. Cantell K., Hirvonen S., Mogensen K. E., Pyhala L. 1974; Human leukocyte interferon: production, purification, stability, and animal experiments. In Interferon, In vitro monograph No. 3, pp 35–38
   [Google Scholar]
5. Cavalieri R. L., Havell E. A., Vilcek J., Pestka S. 1977; Synthesis of human interferon by Xenopus laevis oocytes: Two structural genes for interferons in human cells. Proceedings of the National Academy of Sciences of the United States of America 74:3287–3291
   [Google Scholar]
6. De Maeyer-Guignard J., Tovey M. G., Gresser I., De Maeyer E. 1978; Purification of mouse interferon by sequential affinity chromatography on poly(U)- and antibody-agarose columns. Nature, London 271:622–625
   [Google Scholar]
7. Edy V. G., Billiau A., De Somer P. 1976; Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection. Journal of General Virology 31:251–255
   [Google Scholar]
8. Edy V. G., Billiau A., De Somer P. 1977; Purification of human fibroblast interferon by zinc chelate affinity chromatography. Journal of Biological Chemistry 252:5934–5935
   [Google Scholar]
9. Einhorn S., Strander H. 1977; Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. Journal of General Virology 35:573–577
   [Google Scholar]
10. Fuse A., Kuwata T. 1978; Inhibition of DNA synthesis and alterations of cyclic adenosine 3′, 5′-mono-phosphate levels in RSa cells by human leukocyte interferon. Journal of the National Cancer Institute 60:1227–1232
    [Google Scholar]
11. Gresser I., Bandu M. T., Brouty-Boye D. 1974; Interferon and cell division. IX. Interferon-resistant L 1210 cells: characteristics and origin. Journal of the National Cancer Institute 52:553–559
    [Google Scholar]
12. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. 1975; Two antigenically distinct species of human interferon. Proceedings of the National Academy of Sciences of the United States of America 72:2185–2187
    [Google Scholar]
13. HilfenhaUs J., Damm H., Karges H. E., Manthey K. F. 1976; Growth inhibition of lymphoblastoid Daudi cells in vitro by interferon preparations. Archives of Virology 51:87–97
    [Google Scholar]
14. Hilfenhaus J., Damm H., Hohannsen R. 1977; Sensitivity of various human lymphoblastoid cells to the antiviral and anticellular activity of human leukocyte interferon. Archives of Virology 54:271–277
    [Google Scholar]
15. Kawakita M., Caberer B., Taira H., Rebello M., Slattery E., Weidel H., Lengyel P. 1978; Purification of interferon from mouse Ehrlich ascites tumor cells. Journal of Biological Chemistry 252:598–602
    [Google Scholar]
16. Knight E. Jun 1976; Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature, London 262:302–303
    [Google Scholar]
17. Kuwata T., Fuse A., Morinaga N. 1976; Effects of interferon on cell and virus growth in transformed human cell lines. Journal of General Virology 33:7–15
    [Google Scholar]
18. Kuwata T., Fuse A., Morinaga N. 1977a; Effects of ouabain on the anticellular and antiviral activities of human and mouse interferon. Journal of General Virology 34:537–540
    [Google Scholar]
19. Kuwata T., Fuse A., Morinaga N. 1977b; Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon. Journal of General Virology 37:195–198
    [Google Scholar]
20. Mankovitz R., Buckwald M., Baker R. M. 1974; Isolation of ouabain-resistant human diploid fibroblasts. Cell 3:221–226
    [Google Scholar]
21. Stewart W. E. II, De Somer P., Edy V. G., Paucker K., Berg K., Ogburn C. A. 1975; Distinct molecular species of human interferons: requirements for stabilization and reactivation of human leukocyte and fibroblast interferons. Journal of General Virology 26:327–331
    [Google Scholar]
22. Stewart W. E. II, Gresser L., Tovey M. G., Bandu M. T., Goff Sl. L. 1976; Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature, London 252:300–302
    [Google Scholar]
23. Vilcek J., Havell E. A. 1973; Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature. Proceedings of the National Academy of Sciences of the United States of America 70:3909–3913
    [Google Scholar]
24. Vilcek J., Havell E. A., Yamazaki S. 1977; Antigenic, physicochemical, and biologic characterization of human interferons. Annals of the New York Academy of Sciences 284:703–710
    [Google Scholar]